Table 1 Baseline characteristics and medical treatment of patients

Age (years)

60.7 ± 7.4

Male, n (%)

3 (100)

BMI (kg/m²)

27.3 ± 1.4

Smoking, n (%)

1 (33.3)

Hypertension, n (%)

3 (100)

Hyperlipidemia, n (%)

2 (66.7)

Leukocyte (10⁹/L)

6.0 ± 0.6

Platelet (10⁹/L)

197.3 ± 10.7

FBG (mmol/L)

5.5 ± 1.0

2h-PG (mmol/L)

10.5 ± 3.4

HbA1c (%)

7.0 ± 1.1

Blood urea nitrogen (mmol/L)

4.5 ± 0.3

Creatinine (μmol/L)

75.0 ± 6.7

Uric acid (mmol/L)

290.0 ± 37.6

hs-CRP (mg/L)

1.0 ± 0.5

Triglyceride (mmol/L)

1.2 ± 0.2

Total cholesterol (mmol/L)

4.7 ± 0.3

HDL-cholesterol (mmol/L)

1.1 ± 0.2

LDL-cholesterol (mmol/L)

3.2 ± 0.3

Lipoprotein (a) (g/L)

0.1 ± 0.03

Medications, n (%)

 Anti-platelet

3 (100)

 Beta-blocker

2 (66.7)

 ACE-I/ARB

2 (66.7)

 Statin

3 (100)